tiprankstipranks
Evolus, Inc. (EOLS)
NASDAQ:EOLS
US Market
EOLS
Evolus
RESEARCH TOOLSreports
Want to see EOLS full AI Analyst Report?

Evolus (EOLS) Stock Forecast & Price Target

575 Followers
See the Price Targets and Ratings of:

EOLS Analyst Ratings

Strong Buy
5Ratings
Strong Buy
4 Buy
1 Hold
0 Sell
Based on 5 analysts giving stock ratings to
Evolus
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

EOLS Stock 12 Month Forecast

Average Price Target

$14.50
▲(209.17% Upside)
Based on 5 Wall Street analysts offering 12 month price targets for Evolus in the last 3 months. The average price target is $14.50 with a high forecast of $17.00 and a low forecast of $13.00. The average price target represents a 209.17% change from the last price of $4.69.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"3":"$3","18":"$18","6.75":"$6.75","10.5":"$10.5","14.25":"$14.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":17,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$17.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":14.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$14.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":13,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$13.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[3,6.75,10.5,14.25,18],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2025","6":"Dec<br/>2025","9":"Mar<br/>2026","12":"Jun<br/>2026","25":"Jun<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,6.52,7.326153846153845,8.132307692307691,8.938461538461539,9.744615384615384,10.55076923076923,11.356923076923078,12.163076923076924,12.96923076923077,13.775384615384615,14.581538461538461,15.387692307692308,16.193846153846152,{"y":17,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,6.52,7.133846153846154,7.747692307692308,8.361538461538462,8.975384615384616,9.58923076923077,10.203076923076923,10.816923076923077,11.430769230769231,12.044615384615385,12.65846153846154,13.272307692307692,13.886153846153846,{"y":14.5,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,6.52,7.018461538461538,7.516923076923076,8.015384615384615,8.513846153846153,9.012307692307692,9.510769230769231,10.009230769230768,10.507692307692308,11.006153846153847,11.504615384615384,12.003076923076923,12.501538461538463,{"y":13,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":9.97,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.2,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.15,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.5,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.15,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.46,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.82,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.65,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.91,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.29,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.31,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.33,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.52,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$17.00Average Price Target$14.50Lowest Price Target$13.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
BTIG Analyst forecast on EOLS
Sam Eiber
BTIG
BTIG
$13
Buy
177.19%
Upside
Reiterated
06/17/26
Evolus Reaffirmed at Buy as Analyst Sees Path to Profitability and Maintains $13 Price Target
Mizuho Securities Analyst forecast on EOLS
Uy Ear
Mizuho Securities
Mizuho Securities
$15
Buy
219.83%
Upside
Reiterated
06/08/26
Evolus (EOLS) Receives a Buy from Mizuho Securities
H.C. Wainwright Analyst forecast on EOLS
Douglas Tsao
H.C. Wainwright
H.C. Wainwright
$13
Buy
177.19%
Upside
Reiterated
05/05/26
Evolus Maintains Buy Rating as Scalable Growth Story Solidifies; $13 Price Target Reaffirmed
Stifel Nicolaus Analyst forecast on EOLS
Annabel Samimy
Stifel Nicolaus
Stifel Nicolaus
$17
Buy
262.47%
Upside
Reiterated
05/05/26
Analysts Are Bullish on Top Healthcare Stocks: CG Oncology, Inc. (CGON), Evolus (EOLS)
Needham Analyst forecast on EOLS
Serge Belanger
Needham
Needham
―
Hold
―
Reiterated
05/05/26
Analysts Offer Insights on Healthcare Companies: ADC Therapeutics (NYSE: ADCT), Evolus (NASDAQ: EOLS) and Nuvation Bio (NYSE: NUVB)
Leerink Partners Analyst forecast on EOLS
Marc Goodman
Leerink Partners
Leerink Partners
―
Buy
―
Reiterated
10/07/25
Leerink Partners Keeps Their Buy Rating on Evolus (EOLS)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
BTIG Analyst forecast on EOLS
Sam Eiber
BTIG
BTIG
$13
Buy
177.19%
Upside
Reiterated
06/17/26
Evolus Reaffirmed at Buy as Analyst Sees Path to Profitability and Maintains $13 Price Target
Mizuho Securities Analyst forecast on EOLS
Uy Ear
Mizuho Securities
Mizuho Securities
$15
Buy
219.83%
Upside
Reiterated
06/08/26
Evolus (EOLS) Receives a Buy from Mizuho Securities
H.C. Wainwright Analyst forecast on EOLS
Douglas Tsao
H.C. Wainwright
H.C. Wainwright
$13
Buy
177.19%
Upside
Reiterated
05/05/26
Evolus Maintains Buy Rating as Scalable Growth Story Solidifies; $13 Price Target Reaffirmed
Stifel Nicolaus Analyst forecast on EOLS
Annabel Samimy
Stifel Nicolaus
Stifel Nicolaus
$17
Buy
262.47%
Upside
Reiterated
05/05/26
Analysts Are Bullish on Top Healthcare Stocks: CG Oncology, Inc. (CGON), Evolus (EOLS)
Needham Analyst forecast on EOLS
Serge Belanger
Needham
Needham
―
Hold
―
Reiterated
05/05/26
Analysts Offer Insights on Healthcare Companies: ADC Therapeutics (NYSE: ADCT), Evolus (NASDAQ: EOLS) and Nuvation Bio (NYSE: NUVB)
Leerink Partners Analyst forecast on EOLS
Marc Goodman
Leerink Partners
Leerink Partners
―
Buy
―
Reiterated
10/07/25
Leerink Partners Keeps Their Buy Rating on Evolus (EOLS)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Evolus

3 Months
Uy EarMizuho Securities
Success Rate
12/35 ratings generated profit
34%
Average Return
-4.75%
Copying Uy Ear's trades and holding each position for 3 Months would result in 34.29% of your transactions generating a profit, with an average return of -4.75% per trade.
1 Year
Marc GoodmanLeerink Partners
Success Rate
14/31 ratings generated profit
45%
Average Return
-7.61%
Copying Marc Goodman's trades and holding each position for 1 Year would result in 45.16% of your transactions generating a profit, with an average return of -7.61% per trade.
2 Years
Marc GoodmanLeerink Partners
Success Rate
13/31 ratings generated profit
42%
Average Return
-9.72%
Copying Marc Goodman's trades and holding each position for 2 Years would result in 41.94% of your transactions generating a profit, with an average return of -9.72% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

EOLS Analyst Recommendation Trends

Rating
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Strong Buy
10
10
8
10
8
Buy
0
0
0
0
0
Hold
2
2
2
3
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
12
12
10
13
10
In the current month, EOLS has received 8 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. EOLS average Analyst price target in the past 3 months is 14.50.
Each month's total comprises the sum of three months' worth of ratings.

EOLS Financial Forecast

EOLS Earnings Forecast

Next quarter’s earnings estimate for EOLS is -$0.04 with a range of -$0.07 to $0.01. The previous quarter’s EPS was -$0.05. EOLS beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year EOLS has Performed in-line its overall industry.
Next quarter’s earnings estimate for EOLS is -$0.04 with a range of -$0.07 to $0.01. The previous quarter’s EPS was -$0.05. EOLS beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year EOLS has Performed in-line its overall industry.

EOLS Sales Forecast

Next quarter’s sales forecast for EOLS is $81.89M with a range of $79.20M to $84.20M. The previous quarter’s sales results were $73.14M. EOLS beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year EOLS has Performed in-line its overall industry.
Next quarter’s sales forecast for EOLS is $81.89M with a range of $79.20M to $84.20M. The previous quarter’s sales results were $73.14M. EOLS beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year EOLS has Performed in-line its overall industry.

EOLS Stock Forecast FAQ

What is EOLS’s average 12-month price target, according to analysts?
Based on analyst ratings, Evolus, Inc.’s 12-month average price target is 14.50.
    What is EOLS’s upside potential, based on the analysts’ average price target?
    Evolus, Inc. has 209.17% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is EOLS a Buy, Sell or Hold?
          Evolus, Inc. has a consensus rating of Strong Buy which is based on 4 buy ratings, 1 hold ratings and 0 sell ratings.
            What is Evolus, Inc.’s price target?
            The average price target for Evolus, Inc. is 14.50. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $17.00 ,the lowest forecast is $13.00. The average price target represents 209.17% Increase from the current price of $4.69.
              What do analysts say about Evolus, Inc.?
              Evolus, Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 5 Wall Streets Analysts.
                How can I buy shares of EOLS?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.